Downloads

Abzena plc 2018 Annual Report

Abzena plc 2018 Annual Report

Download

MHC Associated Peptide Proteomics

Case Study MAPPs for Vaccine Design To identify MHC class I presented antigens derived from influenza strain H1N1, two[...]

Download

World ADC Presentation 2017

Abzena’s presentation at World ADC 2017 given by Campbell Bunce – Senior Vice President Technical Operations.

Download

Composite Proteins™ Fact Sheet

More information on Abzena’s Composite Protein™ technology. Protein Deimmunisation Technical Flyer

Download

Optimisation of Pharmacokinetics Fact Sheet

Information on a our PEGylation technologies, including a TheraPEG case study on the PEGylation of interferon (IFN) a-2b

Download

Composite Human Antibodies™ Fact Sheet

More information on our antibody humanisation and deimmunisation technology, including a case study on the deimmunisation[...]

Download

iTope™ and TCED™ Fact Sheet

More information on Abzena’s iTope™ and TCED™ technology including a detailed look at the results.

Download

EpiScreen™ Time Course T Cell Assay Fact Sheet

More information on the EpiScreen™ time course T cell assay and a case study showing the potential immunogenicity[...]

Download

Events

WADC London 2022

29 March 2022

Our team, Nicolas Camper, Jonathan Cruickshank, Swati Chatterjee, Patrick Haddad and Mark Frigerio are excited to[...] Read more

WEBINAR – ADC Developability for successful lead candidate selection

22 September 2021

We are doing a webinar on the 22nd September at 3pm BST/10am EDT. Register for the webinar here. Antibody-drug conjugates[...] Read more

References

Stability of Maleimide-PEG and Mono-Sulfone-PEG Conjugation to a Novel Engineered Cysteine in the Human Hemoglobin Alpha Subunit

In order to use a Hemoglobin Based Oxygen Carrier as an oxygen therapeutic or blood substitute, it is necessary to[...] Read more

Addressing the Challenges of Bioconjugate Medicines

The continuing advancements in bioconjugate medicines from delivery of potent cytotoxins to vaccine-, oligonucleotide-,[...] Read more

Antibody-Drug Conjugates

This volume looks at key methodologies that are commonly used across antibody drug conjugates (ADCs) programs. The[...] Read more

Integrating ADC Manufacturing for the Future

Antibody–drug conjugates (ADCs) in development target many indications beyond cancer and consist of a multitude of[...] Read more

Antibody Drug Conjugates of Cleavable Amino-alkyl and Aryl Maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have[...] Read more

Antibody drug conjugates of cleavable amino-alkyl and aryl maytansinoids

Natural products have been used for many medicinal purposes for centuries. Antibody drug conjugates (ADCs) have utilized[...] Read more

Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody–Drug Conjugate Payload

Antibody–drug conjugates (ADCs) represent an important class of emerging cancer therapeutics. Recent ADC development[...] Read more

Design and Synthesis of Isoquinolidinobenzodiazepine Dimers, a Novel Class of Antibody-Drug Conjugate Payload

Antibody–drug conjugates (ADCs) represent an important class of emerging cancer therapeutics. Recent ADC development[...] Read more

Modulation of drug-linker design to enhance in vivo potency of homogeneous antibody-drug conjugates

Antibody-drug conjugates (ADCs) are a promising class of anticancer agents which have undergone substantial development[...] Read more

Stable and Homogeneous Drug Conjugation by Sequential Bis-Alkylation at Disulphide Bonds Using Bis-Sulphone Reagents

Antibody drug conjugates (ADCs) have begun to have a tremendous impact on the treatment of cancer and other pathological[...] Read more

News

Abzena announces appointment of Petra Dieterich as Scientific Lead

Abzena, the leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of[...] Read more

Abzena Opens a New Biologics Testing Lab to Support Partners Programs

Abzena, a leading Partner Research Organization (PRO) providing integrated discovery, development and manufacturing of[...] Read more

Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity

Investment from Welsh, Carson, Anderson & Stowe and Biospring Partners allows Abzena to expand manufacturing[...] Read more

Abzena, Alira Health and Oncodesign launch DRIVETM-Biologics to support access to specialist services from discovery to clinical development for oncology and inflammation

Consortium provides a unique integrated solution with specialist services, from biologics discovery to clinical and[...] Read more

Abzena appoints Kevin Lundquist as Chief Financial Officer

Cambridge, UK and San Diego, CA, February 1, 2022 – Abzena, a leading Partner Research Organization (PRO) for[...] Read more

Abzena appoints Jim Kennamer as SVP and Site Head of North Carolina

 Cambridge, UK and San Diego, CA, January 20, 2022 – Abzena, a leading Partner Research Organization (PRO) for[...] Read more

Abzena Promotes Troy Wright to Senior Vice President and Global Head of Quality

Cambridge, UK and San Diego, CA, 15 December 2021 – Abzena, the leading Partner Research Organization (PRO) for[...] Read more

Abzena Promotes Dr. Louise Duffy as Chief Technical Officer

Cambridge, UK and San Diego, CA, 26 October 2021 – Abzena, the leading Partner Research Organization (PRO) for[...] Read more

Abzena and evitria announce partnership to provide best in class lead candidate selection.

Abzena, a Partner Research Organization for integrated discovery to GMP solutions for biologics and[...] Read more

Abzena and BioXpress Therapeutics announce partnership to support the development and manufacture of biosimilars for global customers.

Abzena, a Global Partner Research Organization for integrated bench to patient solutions for biologics and[...] Read more

Abzena announces location of new biologics GMP manufacturing site with up to 12 X 2000L bioreactors

Abzena is a Global Partner Research Organization (PRO) specializing in the integrated development and manufacture of[...] Read more

Interested in our services? Get In Touch